Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Y Gillespie

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Survey of Immunologic Research|January 1, 1982
The golden age of mononuclear phagocytesG Y Gillespie
Hybridoma|February 1, 1994
Monoclonal antibodies to glioma-derived growth factor(s)E Lyon, G Y Gillespie
Journal of Neuro-Oncology|August 1, 1993
Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MGE Lyon, G Y Gillespie
International Journal of Cancer|December 15, 1975
Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomasG W Wood, G Y Gillespie
Cellular Immunology|September 1, 1974
Cyclic variations in cell-mediated immunity to skin allografts detected by the technetium-99m microcytotoxicity assayG Y Gillespie, R F Barth
International Journal of Cancer|January 15, 1978
Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomasG Y Gillespie, S W Russell
Cancer|June 1, 1978
Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cellsG Y Gillespie, R F Barth
Clinical Neurosurgery|January 1, 1983
New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapyM S Mahaley, G Y Gillespie
Cellular Immunology|January 1, 1974
The use of technetium-99m as a radioisotopic label to assess cell-mediated immunity in vitroR F Barth, G Y Gillespie
Progress in Experimental Tumor Research|January 1, 1984
Immunotherapy of patients with glioma: fact, fancy, and futureM S Mahaley, G Y Gillespie
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Survey of Immunologic Research|January 1, 1982
The golden age of mononuclear phagocytesG Y Gillespie
Hybridoma|February 1, 1994
Monoclonal antibodies to glioma-derived growth factor(s)E Lyon, G Y Gillespie
Journal of Neuro-Oncology|August 1, 1993
Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MGE Lyon, G Y Gillespie
International Journal of Cancer|December 15, 1975
Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomasG W Wood, G Y Gillespie
Cellular Immunology|September 1, 1974
Cyclic variations in cell-mediated immunity to skin allografts detected by the technetium-99m microcytotoxicity assayG Y Gillespie, R F Barth
International Journal of Cancer|January 15, 1978
Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomasG Y Gillespie, S W Russell
Cancer|June 1, 1978
Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cellsG Y Gillespie, R F Barth
Clinical Neurosurgery|January 1, 1983
New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapyM S Mahaley, G Y Gillespie
Cellular Immunology|January 1, 1974
The use of technetium-99m as a radioisotopic label to assess cell-mediated immunity in vitroR F Barth, G Y Gillespie
Progress in Experimental Tumor Research|January 1, 1984
Immunotherapy of patients with glioma: fact, fancy, and futureM S Mahaley, G Y Gillespie
Pageof 12